Lifecore Biomedical, Inc. LFCR Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s accrued expenses and other liabilities?
- Lifecore Biomedical, Inc. (LFCR) reported accrued expenses and other liabilities of -$3.65M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s accrued expenses and other liabilities changed year-over-year?
- Lifecore Biomedical, Inc.'s accrued expenses and other liabilities decreased by 4.4% year-over-year, from -$3.5M to -$3.65M.